Pyrexar Medical In The News

ASTRO2015Salt Lake City, UT– Pyrexar Medical, leaders in thermal therapy systems, will be exhibiting at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting held in San Antonio’s Henry B. Gonzalez Convention Center on October 18-20,2015.

Pyrexar will showcase their line of superficial, interstitial and deep regional hyperthermia systems for the treatment of cancer. Clinical studies confirm that hyperthermia added to radiotherapy boosts effective dose and increases response rate without any cumulative damage to healthy tissues. Thermal Therapy is one of the most important new cancer therapies on the market and it is under-represented in the U.S.  Pyrexar will be the only manufacturer of this technology exhibiting at the show.

It has been a very big year for the newly formed Pyrexar. Since purchasing the assets from the 30-year-old device manufacturer BSD Medical, the company has experienced phenomenal growth. This growth coincides with important clinical findings supporting the use of thermal therapy, aka hyperthermia, to treat cancer. The most recent peer review (published in Cancer Treatment Reviews) of 38 clinical studies, including cancers of the bladder, breast, cervical, esophageal, head & neck, pediatric tumors, rectal and soft tissue sarcoma, concludes that adding hyperthermia to traditional cancer treatment improves outcomes by an average of 1.8.

“There is no better time to talk about the benefits of thermal therapy than now”, says Mark Falkowski, CEO at Pyrexar Medical.  “We are seeing an improvement in outcomes by adding a pain-free, harm-free treatment protocol to the standard of care.  Why wouldn’t you give that to a loved one if it could mean more time.” Pyrexar will be launching its #OneMoreYear campaign at the show, challenging everyone to think about what they would do if given one more year.

You can find Pyrexar at booth 1753 at the ASTRO show October 18, 19 & 20 and later this year at RSNA Nov. 29th - Dec 4th in Chicago. To learn more about Pyrexar products and be part of the #OneMoreYear campaign, visit

Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR HyperThermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity to healthy tissues.